EUVIMEDEUVIMED entdecken
Crossref

Translation of Enhanced Bioavailability of a Nano-Micellar Curcumin Formulation (Biowell Lytox+) into Improved Clinical Outcomes in Acne-Prone Skin: A Pharmacokinetic and Exploratory Clinical Study

MEDS Basic Medicine · 2026 · 4 (1)

DOI: 10.23977/medbm.2026.040106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MEDS Basic Medicine, 2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

: This study evaluated the pharmacokinetic profile of a nano-micellar liquid curcumin formulation (Biowell Lytox+) and its clinical effects on acne-prone skin through a single-dose crossover pharmacokinetic trial and a 12-week clinical evaluation. Pharmacokinetic results showed that, compared with native curcumin powder, the nano-micellar formulation achieved a 193-fold increase in relative bioavailability (p

Zitieren

APA

(2026). Translation of Enhanced Bioavailability of a Nano-Micellar Curcumin Formulation (Biowell Lytox+) into Improved Clinical Outcomes in Acne-Prone Skin: A Pharmacokinetic and Exploratory Clinical Study. MEDS Basic Medicine, 4(1). https://doi.org/10.23977/medbm.2026.040106

Vancouver

Translation of Enhanced Bioavailability of a Nano-Micellar Curcumin Formulation (Biowell Lytox+) into Improved Clinical Outcomes in Acne-Prone Skin: A Pharmacokinetic and Exploratory Clinical Study. MEDS Basic Medicine. 2026;4(1). doi:10.23977/medbm.2026.040106

BibTeX
@article{euvimed2026,
  title = {Translation of Enhanced Bioavailability of a Nano-Micellar Curcumin Formulation (Biowell Lytox+) into Improved Clinical Outcomes in Acne-Prone Skin: A Pharmacokinetic and Exploratory Clinical Study},
  journal = {MEDS Basic Medicine},
  year = {2026},
  volume = {4},
  number = {1},
  doi = {10.23977/medbm.2026.040106}
}
Kostenlos starten →